Filter

281 - 290 of 406 Results

  • The President’s FY 2006 Budget Proposal:

    Report

    Overview and Briefing Charts This chartpack reviews the President’s FY 2006 budget request to Congress and highlights overall budget assumptions and funding for major health programs. It begins with a description of the federal budget process, followed by an overview of federal surplus/deficit spending patterns dating back to 1969.

  • Impact of Pharmaceutical Promotion on the Use of Antidepressant Medication

    Other Post

    Two recent articles have been published on the impact of direct-to-consumer advertising (DTCA) on the use of antidepressants, based on research by researchers at Harvard University and the Massachusetts Institute of Technology, and funded in part by the Kaiser Family Foundation.

  • Section 12: Employer Opinions and Health Management Programs

    Report

    Exhibit 12.1 Exhibit 12.6 Exhibit 12.2 Exhibit 12.7 Exhibit 12.3 Exhibit 12.8 Exhibit 12.4 Exhibit 12.9 Exhibit 12.5   12 Kaiser Family Foundation, Kaiser Commission on Medicaid and the Uninsured. Health Insurance Coverage in America, 2002 Data Update, December 2003.

  • Section 11: Retiree Health Benefits

    Report

    Exhibit 11.1 Exhibit 11.4 Exhibit 11.2 Exhibit 11.5 Exhibit 11.3   11 Twenty-eight percent of Medicare beneficiaries receive prescription drug coverage from an employer, a far higher number than receive coverage through a Medicare HMO (15%), Medigap (7%) or Medicaid (10%). Laschober et. al., Health Affairs, February 2002.

  • Section 10: Plan Funding

    Report

    Exhibit 10.1 Exhibit 10.5 Exhibit 10.2 Exhibit 10.6 Exhibit 10.3 Exhibit 10.7 Exhibit 10.4   10 A self-funded plan is one in which the employer assumes direct responsibility for the costs of enrollees’ medical claims. Employers sponsoring self-funded plans typically contract with a third-party administrator or insurer to provide administrative services for the self-funded plan.

  • Section 9: Prescription Drugs and Mental Health Benefits

    Report

    Exhibit 9.1 Exhibit 9.5 Exhibit 9.2 Exhibit 9.6 Exhibit 9.3 Exhibit 9.7 Exhibit 9.4 Exhibit 9.8 9 There are fewer observations for estimating the average copayment for four-tier drugs compared to other drug types.

  • Section 6: Employee Contributions for Premiums

    Report

    Exhibit 6.1 Exhibit 6.9 Exhibit 6.2 Exhibit 6.10 Exhibit 6.3 Exhibit 6.11 Exhibit 6.4 Exhibit 6.12 Exhibit 6.5 Exhibit 6.13 Exhibit 6.6 Exhibit 6.14 Exhibit 6.7 Exhibit 6.15 Exhibit 6.